IMBALZANO, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 1.788
AS - Asia 1.221
EU - Europa 676
SA - Sud America 176
AF - Africa 29
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.901
Nazione #
US - Stati Uniti d'America 1.728
SG - Singapore 533
CN - Cina 258
IT - Italia 250
VN - Vietnam 145
BR - Brasile 137
IE - Irlanda 77
DE - Germania 68
HK - Hong Kong 65
FR - Francia 61
KR - Corea 60
SE - Svezia 60
FI - Finlandia 41
BD - Bangladesh 39
IN - India 36
GB - Regno Unito 35
CA - Canada 29
AR - Argentina 19
JP - Giappone 16
NL - Olanda 16
AT - Austria 15
ID - Indonesia 13
MX - Messico 12
ZA - Sudafrica 11
UA - Ucraina 10
AU - Australia 9
IQ - Iraq 9
RU - Federazione Russa 8
TR - Turchia 8
PL - Polonia 7
BE - Belgio 6
HN - Honduras 6
JM - Giamaica 6
PK - Pakistan 6
CI - Costa d'Avorio 4
CO - Colombia 4
EC - Ecuador 4
HR - Croazia 4
MA - Marocco 4
OM - Oman 4
PH - Filippine 4
UY - Uruguay 4
UZ - Uzbekistan 4
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
ES - Italia 3
MY - Malesia 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
DZ - Algeria 2
IR - Iran 2
JO - Giordania 2
LT - Lituania 2
NI - Nicaragua 2
RO - Romania 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
VE - Venezuela 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
KE - Kenya 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
NP - Nepal 1
PF - Polinesia Francese 1
SV - El Salvador 1
Totale 3.901
Città #
Singapore 332
San Jose 286
Chandler 195
Ashburn 172
Santa Clara 158
Dallas 122
Dublin 76
Beijing 68
Turin 60
Seoul 57
Hong Kong 55
Hefei 50
Ho Chi Minh City 49
Los Angeles 47
Lauterbourg 38
Columbus 35
Hanoi 31
New York 31
Nyköping 31
Munich 29
Buffalo 25
The Dalles 25
Milan 24
Helsinki 23
Medford 21
Collegno 20
Torino 20
Bengaluru 18
Princeton 18
Tokyo 16
Hangzhou 15
Turku 15
São Paulo 13
Redondo Beach 12
Verona 12
Wilmington 12
Boston 11
Fairfield 10
Frankfurt am Main 9
Jakarta 9
Montreal 9
Amsterdam 8
Genoa 8
Johannesburg 8
Fremont 7
Guangzhou 7
Hebei 7
Vienna 7
Warsaw 7
Brussels 6
Dhaka 6
Falkenstein 6
Houston 6
Naples 6
Orem 6
Shanghai 6
Biên Hòa 5
Boardman 5
Brooklyn 5
Chengdu 5
Chicago 5
Denver 5
Dong Ket 5
Jacksonville 5
Mexico City 5
Nuremberg 5
Rome 5
Salvador 5
Seattle 5
Abidjan 4
Atlanta 4
Baghdad 4
Da Nang 4
Düsseldorf 4
Frisco 4
Haiphong 4
London 4
Memphis 4
Montevideo 4
Tashkent 4
Washington 4
West Jordan 4
Xi'an 4
Bari 3
Belo Horizonte 3
Bologna 3
Brisbane 3
Cambridge 3
Charlotte 3
Curitiba 3
Kyiv 3
Lahore 3
Lappeenranta 3
Manchester 3
Mumbai 3
Muscat 3
Ninh Bình 3
Norwalk 3
Philadelphia 3
Phoenix 3
Totale 2.532
Nome #
Neurological comorbidity and severity of COVID-19 213
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review 195
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 165
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 131
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 126
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 123
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 123
Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors 122
COVID-19 in Parkinson's disease: Report on prevalence and outcome 120
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease 117
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 115
Neurological comorbidities and COVID-19-related case fatality: A cohort study 112
Time to onset and duration of botulinum toxin efficacy in movement disorders 112
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 106
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 105
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential 104
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 102
Differential response to pallidal deep brain stimulation among monogenic dystonias: Systematic review and meta-analysis 101
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 99
Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease 98
Tuning Deep Brain Stimulation related depression by frequency modulation: a case report 98
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 97
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 97
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection 96
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease 84
Effects of Continuous Dopaminergic Stimulation on Parkinson's Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion 81
NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective 72
Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report 72
Axial Postural Abnormalities in Parkinsonism: Gaps in Predictors, Pathophysiology, and Management 72
Neurological symptoms in adults with Gaucher disease: a systematic review 70
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel 66
Predictors and Pathophysiology of Axial Postural Abnormalities in Parkinsonism: A Scoping Review 65
Unveiling the Unpredictable in Parkinson's Disease: Sensor-Based Monitoring of Dyskinesias and Freezing of Gait in Daily Life 65
Botulinum Toxin for Axial Postural Abnormalities in Parkinson's Disease: A Systematic Review 62
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease 60
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study 56
Theta-Gamma Subthalamic Stimulation for Verbal Fluency in Parkinson's Disease: A Randomized, Crossover Trial 52
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson's disease 45
Subthalamic and nigral stimulation for freezing of gait in Parkinson's disease: Randomized pilot trial 38
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson's disease 28
From RGB-D to RGB-Only: Reliability and Clinical Relevance of Markerless Skeletal Tracking for Postural Assessment in Parkinson's Disease 27
Unraveling gait and balance impairment in cervical dystonia: associated features, functional implications, and the effect of botulinum toxin 24
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 22
Titration Dynamics and Early Treatment Burden in Advanced Parkinson's Disease: A Multicenter Comparison of CSFLI and LCIG Infusion Therapies 20
The interplay between GBA1 status and age of onset on cognitive, motor and non-motor outcomes in Parkinson's disease: multicenter cross-sectional study 11
Nonmotor fluctuations in Parkinson's disease: impact on caregiving and quality of life 4
When perinatal injury is not the answer: A case report of late diagnosis of A TUBB3-related tubulinopathy 4
Totale 3.977
Categoria #
all - tutte 14.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 0 26
2021/2022265 12 10 12 10 20 6 12 13 9 22 77 62
2022/2023436 55 57 16 55 29 101 25 17 43 14 15 9
2023/2024223 27 39 4 7 6 42 2 24 0 19 9 44
2024/2025840 18 62 24 70 206 84 36 42 67 45 60 126
2025/20262.091 204 130 211 244 189 81 253 64 152 290 168 105
Totale 3.977